Article Details
Retrieved on: 2022-11-16 09:18:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Oppenheimer started coverage on shares of POINT Biopharma Global in a report on Monday, October 10th. They set an “outperform” rating and a $20.00 ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here